Reishi vs Cordyceps — functional mushrooms, compared honestly
Reishi (Ganoderma lucidum) and cordyceps (Cordyceps militaris, now usually) sit in different lanes — reishi for "calming, sleep, immune modulation," cordyceps for "exercise performance, oxygen utilisation." Both have a clinical literature that's largely small-trial Chinese-language publications with mixed quality, plus a Western consumer market saturated with mycelium-on-grain products of dubious potency. Real fruiting-body extracts standardised to beta-glucans are the only versions worth considering, and even then the expected effect sizes are modest.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Stress / subjective calm / sleep | Reishi | Triterpene profile aligns with the calming use; small trials show modest improvements in fatigue and sleep quality. |
| Exercise performance / aerobic capacity | Cordyceps militaris | Small trials show modest VO2max and time-to-exhaustion gains at 3 g/day for 3+ weeks. |
| Immune-modulating effect (cancer adjunct) | Reishi (very limited) | Some adjunctive use in oncology centers in Asia; Cochrane review found insufficient evidence as monotherapy. |
| Libido / male sexual function | Cordyceps (weak evidence) | Small trials in older men show modest improvements; effect size modest. |
| Energy / fatigue (general) | Tie / situational | Reishi for stress-related fatigue; cordyceps for exercise-related fatigue. |
| Drug-interaction risk | Cordyceps (slight edge — fewer reported) | Reishi has anticoagulant signal and case reports of bleeding; cordyceps has fewer interactions described. |
How they actually work
Reishi (Ganoderma lucidum) — triterpenes and beta-glucans
Reishi's bioactives are ganoderic-acid triterpenes (alcohol/ethanol-extracted fraction) and 1,3/1,6-beta-glucans (hot-water-extracted fraction). The triterpene fraction is associated with the "calming" effects (proposed adenosine and GABA modulation, plus mild platelet inhibition). The beta-glucan fraction is associated with the immune-modulating effects. A "dual-extracted" reishi product captures both. The vast majority of US-marketed reishi is mycelium grown on rice or grain rather than fruiting body, and the marketed mg-per-capsule often includes the substrate. Look for products standardised to triterpenes (≥2%) and beta-glucans (≥10–20%) from fruiting body.
Cordyceps (Cordyceps militaris) — cordycepin and adenosine analogs
The traditional Tibetan caterpillar fungus Ophiocordyceps sinensis (yarsagumba) is the historical species but is rare, ecologically threatened, and unavailable commercially in any meaningful quantity — virtually all "cordyceps" supplements are Cordyceps militaris, a different species cultivated industrially. The relevant bioactives are cordycepin (3'-deoxyadenosine) and a range of adenosine analogs that influence purine signaling, plus beta-glucans. The proposed exercise mechanism involves cellular ATP synthesis and oxygen utilisation. Look for products standardised to cordycepin content.
The mycelium-on-grain problem
Many US "mushroom" supplements are mycelium cultured on a grain substrate (oats, rice, sorghum), then dried and powdered with the substrate intact. The end product is largely starch (alpha-glucan) with relatively low beta-glucan content. ConsumerLab and independent testing show wide variation. The "fruiting body" specification on the label, combined with a third-party beta-glucan assay, is the only reliable proxy for getting the bioactives.
Reishi clinical evidence — modest, mixed
Small trials of reishi in adults with subjective fatigue, chronic fatigue syndrome, and cancer-related fatigue show modest improvements in Fatigue Symptom Index scores at 1.5–4 g/day for 4–12 weeks. The Cochrane review of reishi for cancer found insufficient high-quality evidence to support reishi as anti-cancer monotherapy; some adjunctive support of QoL endpoints. The sleep and stress claims are anecdote-heavy with sparse RCT support.
Cordyceps clinical evidence — small but consistent for exercise
Small trials in untrained and recreationally trained adults show modest improvements in VO2max, ventilatory threshold, and time-to-exhaustion at 3 g/day for 3 weeks. Effect sizes are small but reproducible. Trials in older adults show small improvements in 6-minute walk distance and subjective fatigue. The performance signal is more consistent than reishi's calming signal.
Dose, form, and timing
Reishi (fruiting body, dual-extracted): 1.5–4 g/day in divided doses, ideally evening. Capsule, powder, or tincture.
Cordyceps militaris (fruiting body): 2–3 g/day, typically taken in the morning or before training. Capsule or powder.
Safety
Reishi has mild antiplatelet activity at higher doses and case reports of bleeding (with surgery, with warfarin). Discontinue 2 weeks before surgery; avoid combining with anticoagulants without prescriber input. Hepatotoxicity has been reported in case series, particularly with powdered raw reishi.
Cordyceps militaris is generally well-tolerated. Theoretical immune-stimulating effects make caution reasonable in users on immunosuppressants or with active autoimmune disease.
What to skip
Multi-ingredient "10 mushroom complex" products that list raw mycelium-on-grain blends without specifying fruiting body, extraction method, or beta-glucan content. "Lab-grown cordyceps sinensis" tinctures sold at premium prices — the species in nearly all supplements is militaris, not sinensis. "Wild reishi" products without testing for heavy metals.
What we'd actually buy
For reishi: a dual-extracted Ganoderma lucidum fruiting-body extract standardised to ≥2% triterpenes and ≥20% beta-glucans, third-party tested. For cordyceps: a Cordyceps militaris fruiting-body extract standardised to ≥0.2% cordycepin and ≥20% beta-glucans, third-party tested. Skip the "10 mushroom blends" unless you can verify per-species sourcing.
Sources
- Jin X, et al. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2016;4(4):CD007731. PMID: 27045603
- Tang W, et al. A randomized, double-blind, placebo-controlled clinical trial of Ganoderma lucidum in chronic fatigue syndrome. Evid Based Complement Alternat Med. 2008;5(4):359–367.
- Hirsch KR, et al. Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. J Diet Suppl. 2017;14(1):42–53. PMID: 27408987
- Chen S, et al. Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. J Altern Complement Med. 2010;16(5):585–590. PMID: 20804368
- Wachtel-Galor S, et al. Ganoderma lucidum (Lingzhi or Reishi): a medicinal mushroom. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. CRC Press; 2011. PMID: 22593926
- Ashraf SA, et al. Cordycepin for health and wellbeing: a potent bioactive metabolite of an entomopathogenic medicinal fungus Cordyceps with its nutraceutical and therapeutic potential. Molecules. 2020;25(12):2735. PMID: 32545666